U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar: July 17-23, 2022
  1. FDA Meetings, Conferences and Workshops

Public Calendar: July 17-23, 2022

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Robert M. Califf, M.D., MACC, Commissioner of Food and Drugs

Event Date: 07/19/2022
Location: Durham, NC
Subject: The Alexandria Summit - Gene Therapy 2022: Advancing Innovation in Gene Therapy - The Regulatory Perspective
FDA Participant/Group: N/A
Non FDA Participant/Group: Government, industry, academia, and other invited participants

Event Date: 07/20/2022
Location: Virtual
Subject: Infant Formula Issues
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Monica Wilkins, Robert Ford, Thomas Evers (Abbott Laboratories);

Event Date: 07/20/2022
Location: Virtual
Subject: Infant Formula Issues
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Molly Fogarty, Tarun Malkani (Gerber Products Company); Stephen Cha (Health and Human Servicesnt); Sameera Fazili, Zach Butterworth (Executive Office of the President);

Event Date: 07/20/2022
Location: Virtual
Subject: Infant Formula Issues
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Stephen Cha (Health and Human Services); Sameera Fazili, Zach Butterworth (Executive Office of the President); Alexandre Biella, Arthur Pike, Audrae Erickson, Geoffroy Ribadeau-Dumas, Robert Cleveland (Reckitt);

Event Date: 07/21/2022
Location: Virtual
Subject: Infant Formula Issues
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several industry groups interested in the infant formula issues

Event Date: 07/21/2022
Location: Washington, DC
Subject: National Academies Forum on Drug Discovery, Development and Translation
FDA Participant/Group: N/A
Non FDA Participant/Group: Government, industry, academia, and other invited participants

Event Date: 07/21/2022
Location: Virtual
Subject: Drug Shortages and COVID Antiviral Emergency Use Authorization (EUA) Restrictions
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several members of the American Society of Health System Pharmacists

Event Date: 07/22/2022
Location: Virtual
Subject: Infant Formula Issues
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Heather Garlich, Matthew McKinney, Steve Markenson (Food Marketing Institute);

Event Date: 07/22/2022
Location: Virtual
Subject: Infant Formula Issues
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Angela Ramirez, Sean Mccluskie, Stephen Cha (Health and Human Services); Laxman Narasimhan (Reckitt);

Official Name: Janet Woodcock, M.D., Principal Deputy Commissioner

Event Date: 07/18/2022
Location: Virtual
Subject: Researching COVID to Enhance Recovery (RECOVER) Executive Committee Meeting
FDA Participant/Group: PETER MARKS;
Non FDA Participant/Group: Executive Committee Members

Official Name: Andi Lipstein Fristedt, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 07/20/2022
Location: Virtual
Subject: Initial Inspection of Covered Produce Safety Farms
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several members from National Association of State Departments of Agriculture (NASDA)

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Erica Jefferson, Associate Commissioner for External Affairs

No Significant Event

Official Name: Jacqueline O'Shaughnessy, Acting Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

Event Date: 07/20/2022
Location: Virtual
Subject: Japanese Ministry of Health, Labor and Welfare : Pharmaceutical and Medical Devices Agency (MHLW:PMDA) Bilateral Meeting
FDA Participant/Group: WILLIAM LEWIS; KERRY LEE; THERESA MULLIN; MARY SLACK;
Non FDA Participant/Group: Fujiwara Yasuhiro, Nakashima Nobumasa , Tamiya Kenichi, Uzu Shinobu (PMDA);

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

No Significant Event

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date: 07/21/2022
Location: Virutal
Subject: Life Sciences Future; MedTech Plenary Session: CDRH Updates
FDA Participant/Group: N/A
Non FDA Participant/Group: Representatives from medical device, diagnostic and digital health organizations

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

Event Date: 07/19/2022
Location: Virtual
Subject: FDA's Nutrition Priorities
FDA Participant/Group: ROBIN MCKINNON;
Non FDA Participant/Group: Members of Trust for America's Health

Event Date: 07/22/2022
Location: Virtual
Subject: FDA's Nutrition Priorities
FDA Participant/Group: N/A
Non FDA Participant/Group: Nadine Gracia (Trust for America's Health);

Official Name: Brian King, Ph.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

Event Date: 07/19/2022
Location: Virtual
Subject: Veterinary Issues of Mutual Interest
FDA Participant/Group: N/A
Non FDA Participant/Group: Representatives of Animal Health Institute (AHI)

Official Name: Tucker Patterson, Ph.D., Acting Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Chief Counsel

Event Date: 07/20/2022
Location: Silver Spring, MD
Subject: Modern Scientific Exchange
FDA Participant/Group: KAREN SCHIFTER; ELIZABETH DICKINSON; DEBORAH CHASAN SLOAN; DOMINIC CIRINCIONE; HARPREET SINGH; WENDY VICENTE; MICHELLE WEINER; AMANDA EDMONDS;
Non FDA Participant/Group: Craig Kuder, David Hyman, David Riggs, John Paul Benitez, Michael John Hulka, Sonia Chen Arnold (Eli Lilly); Jeff Bucholtz, Lisa Dwyer, Sheldon Bradshaw (King & Spalding);

 

Back to Top